OverviewChartNewsTraderScreen

Vectura Group PLC/  GB00BKM2MW97  /

Cboe Europe BXE
10/18/2021  12:00:00 AM Chg. - Volume Bid- Ask- High Low
165.00GBX - 17,204
Turnover(GBP): -		 163.60Bid Size: - 166.20Ask Size: - 165.00 164.90
GlobeNewswire 12/29/2021 EnBiotix, Inc. Closes $11M Pre-Merger Financing
Newsfile Corp 11/30/2021 Awakn Life Sciences Strengthens Executive Leadership Team
GlobeNewswire 11/18/2021 Aerami Therapeutics Appoints Barry Deutsch as Chief Financial Officer
GlobeNewswire 11/11/2021 Aerami Therapeutics Appoints Darlene Deptula-Hicks to its Board of Directors
GlobeNewswire 8/25/2021 Aerami Therapeutics Announces Orphan Drug Designation for Imatinib for the Treatment of Pulmonary Ar...
GlobeNewswire 7/19/2021 RYAH Group Partners with the University of Milan to Develop Conversion Measurement Standards for Dry...
GlobeNewswire 6/24/2021 Aerami Therapeutics Initiates Dosing in Phase 1 Trial of AER-901, Its Proprietary Inhaled Imatinib f...
TeleTrader 5/26/2021 US stocks rise premarket ahead of earnings
TeleTrader 5/26/2021 Carlyle to acquire Vectura for $1.4 billion
GlobeNewswire 2/9/2021 Hangzhou Chance Pharmaceuticals Expands Pipeline with In-Licensing of AER901 from Aerami Therapeutic...
GlobeNewswire 2/9/2021 Aerami Therapeutics Signs License Agreement with Hangzhou Chance Pharmaceuticals Co. Ltd. for Aerami...
GlobeNewswire 9/15/2020 Vectura Group plc - 2020 Interim Results 
GlobeNewswire 6/8/2020 Aerami Therapeutics Signs a Global License Agreement with Vectura Group, Adding an Inhaled Therapy f...
GlobeNewswire 3/17/2020 Vectura Group plc: 2019 Preliminary Results 
GlobeNewswire 10/30/2019 Dry Powder Inhaler Devices Device Pipeline Study 2019: Analysis of Devices under Development, Compan...
GlobeNewswire 10/29/2019 Vectura Group appoints New Chief Executive Officer
GlobeNewswire 9/13/2019 Vectura provides update on GSK Litigation
GlobeNewswire 9/10/2019 Vectura Group plc: Proposed Special Dividend and Share Consolidation, Share Buyback Programme and Di...
GlobeNewswire 8/30/2019 Global Smart Inhalers Market Set to Exceed $1.4 Billion by 2026, Growing at a CAGR of 58.4% During 2...
GlobeNewswire 7/17/2019 Vectura confirms R&D investment priorities, announces a proposed £50 million capital return and a pr...
GlobeNewswire 3/26/2019 Vectura Group plc 2018 Preliminary Results    
GlobeNewswire 2/11/2019 Global Smart Inhalers Market Report 2019: Size, Market Share, Application Analysis, Regional Outlook...
GlobeNewswire 12/17/2018 Chronic Respiratory Disease Drug Development Pipeline Review, 2018: Therapeutics Under Development a...
GlobeNewswire 9/25/2018 Dance Biopharm Holdings announces the appointment of Anne Whitaker as Chief Executive Officer
GlobeNewswire 9/11/2018 Vectura Group plc: Interim Results